Skip to main content
Kevin Kalinsky, MD, Oncology, Atlanta, GA

KevinMKalinskyMDMS

Oncology Atlanta, GA

Hematologic Oncology

Associate Professor of Medicine, Winship Cancer Institute at Emory University

Dr. Kalinsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kalinsky's full profile

Already have an account?

  • Office

    1365 Clifton Rd NE
    Atlanta, GA 30322
    Phone+1 404-778-1900
    Fax+1 212-305-0178

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2008 - 2009
  • Tufts Medical Center
    Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
  • Tufts Medical Center
    Tufts Medical CenterResidency, Internal Medicine, 2002 - 2005
  • Medical University of South Carolina
    Medical University of South CarolinaClass of 2002

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2020 - 2025
  • NY State Medical License
    NY State Medical License 2008 - 2025
  • MA State Medical License
    MA State Medical License 2006 - 2008
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Capivasertib in Patients with an AKT1 E17K-Mutated Tumor  
    Kevin Kalinsky, Edith P Mitchell, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Alice P Chen, Keith T Flaherty, JAMA Oncology

Lectures

  • Enhancing Checkpoint Inhibitors in Triple-Negative Breast Cancer. Breast Cancer Immunotherapy: Can We Crack the Code? 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
  • Phase IB trial of ACY-1215 (Ricolinostat) combined with nab-paclitaxel in metastatic breast cancer. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • New Chief Surgical Officer at Winship Cancer Institute of Emory University – Tari King, MD
    New Chief Surgical Officer at Winship Cancer Institute of Emory University – Tari King, MDMarch 10th, 2025
  • The Evolving Landscape of CDK4/6i Therapy in Metastatic Breast Cancer: Experts Discuss Key Findings and Future Directions
    The Evolving Landscape of CDK4/6i Therapy in Metastatic Breast Cancer: Experts Discuss Key Findings and Future DirectionsMarch 9th, 2025
  • RSClin Tool N+ Enhances Breast Cancer Risk Estimates
    RSClin Tool N+ Enhances Breast Cancer Risk EstimatesJanuary 23rd, 2025
  • Join now to see all

Grant Support

  • Breast Cancer Brain Metastasis Therapy by Focused Ultrasound-Guided Control of HER2 CAR T cellsGEORGIA INSTITUTE OF TECHNOLOGY2023–2028